Effects of intermediate-conductance Ca2+-activated K+ channel modulators on human prostate cancer cell proliferation.

Parihar, Ashutosh S; Coghlan, Michael J; Gopalakrishnan, Murali; Shieh, Char-Chang

Parihar, Ashutosh S; Coghlan, Michael J; Gopalakrishnan, Murali; Shieh, Char-Chang.

Affiliation

Parihar AS; Neuroscience Research, Global Pharmaceutical Research and Development, Department R4PM, Building AP9A, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064-6125, USA.

Eur J Pharmacol ; 471(3): 157-64, 2003 Jun 27.

Article in En | MEDLINE | ID: mdl-12826234

Subject(s)

Calcium Channel Agonists/pharmacology; Calcium Channel Blockers/pharmacology; Potassium Channels, Calcium-Activated/agonists; Potassium Channels, Calcium-Activated/antagonists & inhibitors; Prostatic Neoplasms/drug therapy; Benzimidazoles/pharmacology; Benzimidazoles/therapeutic use; Calcium Channel Agonists/therapeutic use; Calcium Channel Blockers/therapeutic use; Cell Division/drug effects; Cell Division/physiology; Cell Line, Tumor/cytology; Cell Line, Tumor/drug effects; Cell Line, Tumor/physiology; Dose-Response Relationship, Drug; Humans; Male; Potassium Channels, Calcium-Activated/physiology; Prostatic Neoplasms/pathology; Riluzole/pharmacology; Riluzole/therapeutic use

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Prostatic Neoplasms / Calcium Channel Agonists / Calcium Channel Blockers / Potassium Channels, Calcium-Activated Limits: Humans / Male Language: En Year: 2003 Type: Article

Search on Google

XML

PubMed Links